In vitro release of vascular endothelial growth factor during platelet aggregation

被引:165
作者
Maloney, JP
Silliman, CC
Ambruso, DR
Wang, J
Tuder, RM
Voelkel, NF
机构
[1] Univ Colorado, Sch Med, Dept Pulm Sci, Denver, CO 80262 USA
[2] Univ Colorado, Sch Med, Dept Pathol, Denver, CO 80262 USA
[3] Univ Colorado, Sch Med, Dept Pediat, Denver, CO 80262 USA
[4] Bonfils Blood Ctr, Denver, CO 80262 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 1998年 / 275卷 / 03期
关键词
coagulation; vascular permeability; abciximab; Dami cell;
D O I
10.1152/ajpheart.1998.275.3.H1054
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Platelet aggregation is a cardinal feature of both vascular repair and vascular disease. During aggregation platelets release a variety of vasoactive substances; some of these promote angiogenesis, endothelial permeability, and endothelial growth, actions shared by vascular endothelial growth factor (VEGF). This study was undertaken to investigate the hypothesis that VEGF is released by aggregating platelets. We found that VEGF was secreted during the in vitro aggregation of platelet-rich plasma induced by thrombin, collagen, epinephrine, and ADP (range 23-518 pg VEGF/ml). Furthermore, serum VEGF levels were elevated compared with plasma (230 +/- 63 vs. 38 +/- 8 pg VEGF/ml), indicative of VEGF release during whole blood coagulation. Lysates of apheresed, leukocyte-poor platelet units contained significant amounts of VEGF (2.4 +/- 0.8 pg VEGF/mg protein). VEGF message and protein were also present in a megakaryocytic cell line (Dami cell). These results suggest constitutive roles for platelet VEGF in the repair of intimal vessel injury and in the altered permeability and intimal proliferation seen at sites of platelet aggregation and thrombosis.
引用
收藏
页码:H1054 / H1061
页数:8
相关论文
共 37 条
[1]  
Ambruso D. R., 1996, Blood, V88, p334A
[2]   LACTOFERRIN ENHANCES HYDROXYL RADICAL PRODUCTION BY HUMAN-NEUTROPHILS, NEUTROPHIL PARTICULATE FRACTIONS, AND AN ENZYMATIC GENERATING-SYSTEM [J].
AMBRUSO, DR ;
JOHNSTON, RB .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 67 (02) :352-360
[3]   VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) GENE IS EXPRESSED DIFFERENTIALLY IN NORMAL-TISSUES, MACROPHAGES, AND TUMORS [J].
BERSE, B ;
BROWN, LF ;
VANDEWATER, L ;
DVORAK, HF ;
SENGER, DR .
MOLECULAR BIOLOGY OF THE CELL, 1992, 3 (02) :211-220
[4]  
BREIER G, 1992, DEVELOPMENT, V114, P521
[5]   USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].
CALIFF, RM ;
SHADOFF, N ;
VALETT, N ;
BATES, E ;
GALEANA, A ;
KNOPF, W ;
SHAFTEL, J ;
BENDER, MJ ;
AVERSANO, T ;
RAQUENO, J ;
GURBEL, P ;
COWFER, J ;
COHEN, M ;
CROSS, P ;
BITTL, J ;
EDDINGS, K ;
TAYLOR, M ;
DEROSA, K ;
HATTEL, L ;
COOPER, L ;
ESHELMAN, B ;
FINTEL, D ;
NIEMYSKI, P ;
KLEIN, L ;
KENNEDY, H ;
THORNTON, T ;
KEREIAKES, D ;
MARTIN, L ;
ANDERSON, L ;
HIGBY, N ;
ELLIS, S ;
BREZINA, K ;
GEORGE, B ;
CHAPEKIS, A ;
SMITH, D ;
ANWAR, A ;
GERBER, TL ;
PRITCHARD, GL ;
MYLER, R ;
SHAW, R ;
MURPHY, M ;
WARD, K ;
MADIGAN, NP ;
BLANKENSHIP, J ;
HALBERT, M ;
FLANAGAN, C ;
TANNENBAUM, M ;
POLICH, M ;
STEVENSON, C ;
TCHENG, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961
[6]   DIALYZABLE FACTOR IN HUMAN-SERUM OF PLATELET ORIGIN STIMULATES ENDOTHELIAL-CELL REPLICATION AND GROWTH [J].
CLEMMONS, DR ;
ISLEY, WL ;
BROWN, MT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (06) :1641-1645
[7]  
COLLER BS, 1991, HEART CARDIOVASCULAR, V1, P219
[8]   CHARACTERIZATION OF THE INCREASE IN VASCULAR-PERMEABILITY INDUCED BY VASCULAR-PERMEABILITY FACTOR INVIVO [J].
COLLINS, PD ;
CONNOLLY, DT ;
WILLIAMS, TJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 109 (01) :195-199
[9]  
COLMAN RW, 1992, NEWS PHYSIOL SCI, V7, P274
[10]   PITUITARY FOLLICULAR CELLS SECRETE A NOVEL HEPARIN-BINDING GROWTH-FACTOR SPECIFIC FOR VASCULAR ENDOTHELIAL-CELLS [J].
FERRARA, N ;
HENZEL, WJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (02) :851-858